United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$65Mraised across 3 rounds since 2012, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Novo Holdings
Novartis Venture Fund
Abingworth
IpsenFrom a historical funding recordSEC filing: $17M sold, first sale Feb 2014
Reported by finsmes.comSEC filing: $4.0M sold, first sale Aug 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Thesan Pharmaceuticals's investors include Novo Holdings, Novartis Venture Fund, SV Life Sciences, Johnson & Johnson Development Corporation (JJDC) and Novartis, and 4 more on record.
Thesan Pharmaceuticals has raised $65M across 3 rounds since 2012. One round did not disclose an amount, so the total is a floor.
Thesan Pharmaceuticals's most recent round was a Venture in Jan 2016.
Thesan Pharmaceuticals's largest round on record is $49M (Series B), in Feb 2014.
Thesan Pharmaceuticals's first round on record, in Oct 2012, was backed by Novo Holdings and Novartis Venture Fund.
Thesan Pharmaceuticals's latest named round is a Venture, in Jan 2016.
Thesan Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
